The aim of the study was to estimate the type, incidence and causes of donor adverse reactions during and after blood donation in a Greek Blood Bank, where medical staff is responsible for donor selection. 12 173 blood donors were studied for adverse reactions. One-hundred and seven (0.
View Article and Find Full Text PDFBackground: Open-heart procedure is characterized by a high-risk for contracting blood-borne infections. We evaluated the prevalence of several markers of hepatitis viruses (B-E) and human T-cell lymphotropic virus types I/II (HTLV-I/II) in a consecutive series of patients who had undergone open-heart surgery.
Methods: 204 patients and 158 selected age- and sex-matched healthy volunteers were investigated.
BACKGROUND: Blood donors are routinely screened for antibodies to human T-cell lymphotropic viruses type I and II (HTLV-I and HTLV-II) in the United States, Canada, Japan, and some European countries. Previous reports from our group in relatively small numbers of donors have shown a zero prevalence of HTLV-I/II markers in our region. In this study, seven blood banks in the north and west of Greece participated in order to determine whether mandatory screening of blood donations for HTLV-I/II infection should be established.
View Article and Find Full Text PDFClin Exp Obstet Gynecol
March 1998
The lead concentrations in maternal and umbilical cord blood were determined in 50 parturient women at delivery. Twenty-five lived in agricultural areas with low air pollution and 25 lived in urban areas with high air pollution. The mean lead concentrations (mean +/- SD) in maternal and umbilical cord blood and the correlation coefficient of mothers from urban areas with high air pollution were 37.
View Article and Find Full Text PDFBackground: In addition to human immunodeficiency virus, human T-lymphotropic virus types I and II (HTLV-I/II) is prevalent among blood donors in the United States. In Greece, there are no epidemiologic data regarding the prevalence of HTLV-I/II among volunteer blood donors and high-risk groups.
Study Design And Methods: To determine the prevalence of HTLV-I/II infections in northwestern Greece, a seroepidemiologic study was conducted among volunteer blood donors, multiply transfused patients, heroin addicts, and chronic hemodialysis patients.